Jon mentioned that there was no one in the PW trial who would have to be discontinued off the drug. I.e. they were struggling to recruit patients to the trial so they paused it. They were struggling to recruit because there are other competing phase 2 and 3 trials and you can't be on multiple at once, and if our trial is particularly onerous then why would you go on ours compared to a less onerous option. So given that, then it makes sense to pause the trial, fix up the protocol to make it less onerous, and then consider having another go at recruiting. Plus, then you have a less onerous protocol template you can use for the other pre-clinical indications on the way through.
- Forums
- ASX - By Stock
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
Jon mentioned that there was no one in the PW trial who would...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B |
Open | High | Low | Value | Volume |
$20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1378 | $21.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.29 | 218 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 21.240 |
3 | 2798 | 21.230 |
2 | 1055 | 21.210 |
2 | 9379 | 21.200 |
1 | 1805 | 21.180 |
Price($) | Vol. | No. |
---|---|---|
21.300 | 12763 | 1 |
21.350 | 30 | 1 |
21.380 | 471 | 1 |
21.400 | 700 | 1 |
21.410 | 25 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online